DRUG · Mapped RxNorm record
Benralizumab
Normalized identity: benralizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
NCT02869438
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Asthmaverified · MONDO: asthma
Interventions
BenralizumabDRUG · verified · RxNorm: benralizumab
PlaceboOTHER
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
SeoulSouth Korea6HanoverGermany3SantiagoChile3HamburgGermany2PécsHungary2PhiladelphiaPennsylvania, United States1MiamiFlorida, United States1CincinnatiOhio, United States1TampaFlorida, United States1DenverColorado, United States1Oklahoma CityOklahoma, United States1RochesterMinnesota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02869438 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.